Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2022/10/18/2536906/19989/en/Clarus-Therapeutics-Holdings-Inc-Announces-Completion-of-Auction-for-Sale-of-JATENZO-and-Selection-of-Tolmar-Inc-as-Successful-Bidder.html
https://www.globenewswire.com/news-release/2022/09/06/2509977/19989/en/Clarus-Therapeutics-Holdings-Inc-Announces-Plan-for-Near-Term-Sale-of-JATENZO-Using-Structured-Process-Through-Chapter-11-of-the-U-S-Bankruptcy-Code.html
https://www.fiercepharma.com/pharma/clarus-future-looks-hazy-its-pandemic-era-launch-jatenzo-falters-triggering-layoffs-and-rd
https://www.globenewswire.com/news-release/2022/08/18/2501238/19989/en/Clarus-Therapeutics-Reports-Second-Quarter-2022-Financial-and-Operating-Results-and-Announces-Workforce-Reduction.html
https://www.globenewswire.com/news-release/2022/07/28/2487949/19989/en/Clarus-Therapeutics-Announces-Notice-of-Allowance-for-Additional-Patent-Claims-Covering-JATENZO-testosterone-undecanoate.html
https://www.globenewswire.com/news-release/2022/06/09/2459788/19989/en/Clarus-Therapeutics-to-Present-New-Data-for-JATENZO-testosterone-undecanoate-at-ENDO-2022-the-Endocrine-Society-s-Annual-Meeting.html
https://www.globenewswire.com/news-release/2022/05/16/2444316/19989/en/Clarus-Therapeutics-Reports-First-Quarter-2022-Financial-and-Operating-Results.html
https://www.globenewswire.com/news-release/2022/05/12/2442068/19989/en/Clarus-Therapeutics-to-Report-First-Quarter-2022-Financial-and-Operating-Results.html
https://www.globenewswire.com/news-release/2022/05/10/2439862/19989/en/Clarus-Therapeutics-Announces-Notice-of-Allowance-for-Patent-Claims-Covering-CLAR-121-Testosterone-Anastrozole-for-Treatment-of-Androgen-Mediated-Autoimmune-Inflammatory-Mastitis.html
https://www.globenewswire.com/news-release/2022/05/09/2438716/19989/en/Clarus-Therapeutics-to-Present-New-Data-for-JATENZO-testosterone-undecanoate-at-the-2022-American-Urological-Association-Annual-Meeting.html